Sylvamo
SLVM NYSE Paper Products Financials FY2019βFY2025
Sylvamo's revenue fell 11.2% to $3.4 billion in fiscal 2025. Its operating margin was 7.5%, down from 12.0% a year earlier. Free cash flow was $44 million, down 82.3%. It paid out $155 million in dividends and buybacks, 352% of free cash flow. The diluted share count fell 3.1%.
What Sylvamo does
No business description yet.
- Legal name
- SYLVAMO CORPORATION
- Fiscal year ends
- December 31, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0001856485-26-000008
0001856485
Revenue and margins
Sylvamo had $3.4B of revenue in fiscal 2025, down 11.2% on the year before.
Net income and earnings per share
From fiscal 2019 to 2025, diluted EPS grew β14.9% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $44.0M in fiscal 2025, 1.3% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Sylvamo returned $155M to shareholders in fiscal 2025, 352% of free cash flow. The diluted share count fell 3.1%.
Value Sylvamo yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β$651M and divides by 40.7M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 17.4x Β· peers 22.2x Β· sector 20.6x.
Balance sheet
Cash, debt and the ratios that show how comfortably Sylvamo can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $159M | $360M | $220M | $205M | $135M |
| Debt incl. finance leases | $1.4B | $1.0B | $959M | $804M | $786M |
| Net debt / EBITDA | 2.5x | 1.0x | 1.3x | 1.0x | 1.5x |
| Debt / equity | 7.6x | 1.5x | 1.1x | 1.0x | 0.8x |
| Interest coverage | 11.3x | 6.9x | 6.9x | 8.0x | 5.1x |
| Current ratio | 1.5x | 1.7x | 1.7x | 1.6x | 1.5x |
| Quick ratio | 1.1x | 1.2x | 1.1x | 1.0x | 0.9x |
| Total assets | $2.6B | $2.7B | $2.9B | $2.6B | $2.8B |
| Total liabilities | $2.4B | $2.0B | $2.0B | $1.8B | $1.8B |
| Shareholders' equity | $182M | $678M | $901M | $847M | $966M |
| Net debt (β = net cash) | $1.2B | $672M | $739M | $599M | $651M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.8M
4 insiders
Of sales under plans
0%
$0.0M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Jun 15, 2026 | Lizanne M BruceDirector | Sold | 1,230 | $41.70 | $0.1M | Form 4 |
| Mar 17, 2026 | Patrick WilczynskiSVP, Operational Excellence | Sold | 6,000 | $42.28 | $0.3M | Form 4 |
| Mar 9, 2026 | Kevin W FergusonVP, Controller,Chief Acct.Off. | Sold | 2,500 | $42.06 | $0.1M | Form 4 |
| Mar 4, 2026 | Rodrigo DavoliSVP & Gm, North America | Sold | 3,250 | $46.46 | $0.2M | Form 4 |
| Dec 9, 2025 | Kevin W FergusonVP, Controller,Chief Acct.Off. | Sold | 2,000 | $48.25 | $0.1M | Form 4 |
| Nov 14, 2025 | Kevin W FergusonVP, Controller,Chief Acct.Off. | Sold | 1,000 | $45.77 | $0.0M | Form 4 |
| Nov 12, 2025 | Kevin W FergusonVP, Controller,Chief Acct.Off. | Sold | 2,000 | $48.70 | $0.1M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 7 / 8 | 6 / 8 | 5 / 8 |
| Accruals ratio | β9.0% | β6.1% | β5.1% |
| Altman Z'' | 5.17 | 5.71 | 5.00 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Sylvamo SLVM | $1.3B | β11.2% | 7.5% | 1.3% | 10.9% | 17.4x | 5 | |
| Kaiser Aluminum KALU | $1.8B | 11.5% | 5.6% | β0.8% | 7.7% | 8.3x | 7 | Compare β |
| Scotts Miracle-Gro SMG | $3.5B | β3.9% | 10.5% | 8.0% | 13.4% | 50.2x | 6 | Compare β |
| Worthington Steel WS | $2.0B | 11.3% | β0.0% | 2.3% | β0.1% | β | 5 | Compare β |
| Avient AVNT | $3.8B | 0.6% | 6.2% | 6.0% | 4.0% | 22.2x | 6 | Compare β |
7 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | $4.0B | $2.4B | $2.8B | $3.6B | $3.7B | $3.8B | $3.4B |
| Operating income | β | β | β | $553M | $441M | $453M | $251M |
| Interest expense | $5.0M | $4.0M | $32.0M | $80.0M | $64.0M | $57.0M | $49.0M |
| Pretax income | $502M | $95.0M | $328M | $467M | $369M | $405M | $199M |
| Income tax | $125M | $8.0M | $101M | $131M | $116M | $103M | $67.0M |
| Net income | $377M | $170M | $331M | $118M | $253M | $302M | $132M |
| Diluted EPS | $8.55 | $3.85 | $7.53 | $2.66 | $5.93 | $7.18 | $3.24 |
| Diluted shares | 0.04B | 0.04B | 0.04B | 0.04B | 0.04B | 0.04B | 0.04B |
| Cash flow | |||||||
| Cash from operations | $524M | $359M | $549M | $438M | $504M | $469M | $268M |
| Capital expenditure | $118M | $66.0M | $69.0M | $149M | $210M | $221M | $224M |
| Free cash flow | $406M | $293M | $480M | $289M | $294M | $248M | $44.0M |
| Depreciation and amortization | $192M | $135M | $126M | $125M | $143M | $159M | $179M |
| Stock-based compensation | $19.0M | $15.0M | $14.0M | $20.0M | $23.0M | $23.0M | $18.0M |
| Acquisitions | $0.0M | $0.0M | $0.0M | $0.0M | $167M | $0.0M | $0.0M |
| Share buybacks | $0.0M | $0.0M | $0.0M | $80.0M | $70.0M | $69.0M | $82.0M |
| Dividends paid | $0.0M | $0.0M | $0.0M | $10.0M | $57.0M | $62.0M | $73.0M |
| Dividends and buybacks | $0.0M | $0.0M | $0.0M | $90.0M | $127M | $131M | $155M |
| Balance sheet | |||||||
| Cash and short-term investments | $89.0M | $95.0M | $159M | $360M | $220M | $205M | $135M |
| Total debt | β | $22.0M | $1.4B | $1.0B | $959M | $804M | $786M |
| Finance lease liabilities | $0.0M | $23.0M | $22.0M | $17.0M | $16.0M | $14.0M | $15.0M |
| Current assets | β | $1.1B | $1.1B | $1.2B | $1.2B | $1.1B | $1.1B |
| Current liabilities | β | $490M | $758M | $728M | $695M | $682M | $716M |
| Inventory | $0.0M | $342M | $279M | $364M | $404M | $361M | $418M |
| Property and equipment, net | β | $974M | $764M | $817M | $1.0B | $944M | $1.0B |
| Total assets | β | $2.9B | $2.6B | $2.7B | $2.9B | $2.6B | $2.8B |
| Total liabilities | β | $799M | $2.4B | $2.0B | $2.0B | $1.8B | $1.8B |
| Shareholders' equity | $2.5B | $2.1B | $182M | $678M | $901M | $847M | $966M |
| Margins | |||||||
| Operating margin | β | β | β | 15.2% | 11.9% | 12.0% | 7.5% |
| EBITDA margin | 17.4% | 9.8% | 17.2% | 18.7% | 15.7% | 16.2% | 12.8% |
| Net margin | 9.4% | 7.1% | 11.7% | 3.3% | 6.8% | 8.0% | 3.9% |
| FCF margin | 10.1% | 12.3% | 17.0% | 8.0% | 7.9% | 6.6% | 1.3% |
| Returns | |||||||
| Return on capital | β | β | 14.5% | 29.0% | 20.2% | 21.9% | 10.9% |
| Return on capital employed | β | β | 16.9% | 29.0% | 21.2% | 22.1% | 12.7% |
| Return on equity | β | β | 28.9% | 27.4% | 32.1% | 34.6% | 14.6% |
| Return on assets | β | β | 12.0% | 4.5% | 9.1% | 11.0% | 4.9% |
| Growth | |||||||
| Revenue growth | β | β40.6% | 18.6% | 28.3% | 2.6% | 1.4% | β11.2% |
| Net income growth | β | β54.9% | 94.7% | β64.4% | 114.4% | 19.4% | β56.3% |
| EPS growth | β | β55.0% | 95.6% | β64.7% | 122.9% | 21.1% | β54.9% |
| FCF growth | β | β27.8% | 63.8% | β39.8% | 1.7% | β15.7% | β82.3% |
| Share count change | β | 0.0% | 0.0% | 0.9% | β3.8% | β1.6% | β3.1% |
| Financial health | |||||||
| Net debt / EBITDA | β | β0.3x | 2.5x | 1.0x | 1.3x | 1.0x | 1.5x |
| Debt / equity | β | 0.0x | 7.6x | 1.5x | 1.1x | 1.0x | 0.8x |
| Interest coverage | 101.4x | 24.8x | 11.3x | 6.9x | 6.9x | 8.0x | 5.1x |
| Current ratio | β | 2.3x | 1.5x | 1.7x | 1.7x | 1.6x | 1.5x |
| Quick ratio | β | 1.6x | 1.1x | 1.2x | 1.1x | 1.0x | 0.9x |
| Capital allocation | |||||||
| Capex / revenue | 2.9% | 2.8% | 2.4% | 4.1% | 5.6% | 5.9% | 6.7% |
| Stock comp / revenue | 0.5% | 0.6% | 0.5% | 0.6% | 0.6% | 0.6% | 0.5% |
| Payouts / FCF | 0.0% | 0.0% | 0.0% | 31.1% | 43.2% | 52.8% | 352.3% |
| Quality scores | |||||||
| Piotroski F-score | β | β | β | 6.0 | 7.0 | 6.0 | 5.0 |
| Altman Z'' | β | 4.4 | 4.3 | 5.4 | 5.2 | 5.7 | 5.0 |
| Accruals ratio | β | β | β7.9% | β12.1% | β9.0% | β6.1% | β5.1% |
Source: SEC EDGAR XBRL filings (CIK 0001856485). Data updated October 21, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.